Top Markets
#1 Siacoin Siacoin +52.09%
#2 Official Trump Official Trump +35.11%
#3 Melania Meme Melania Meme +22.79%
#4 Nockchain Nockchain +21.64%
#5 EXOD EXOD +18.93%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.88%
#7 MowCat MowCat +18.80%
#8 Mubarak Mubarak +17.99%
#9 Unit Pump Unit Pump +15.74%
#10 Pump.fun Pump.fun +15.74%
Coin of the day
Siacoin Siacoin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classement en actions #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Prix de l'action
$0.17616661
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$73.48M
Changement (1 jour)
0.18%
Changement (1 an)
-37.76%
Pays
TW
Échange Mercury Biopharmaceutical Corporation (6932)

Catégorie

Healthcare
Bénéfices pour Mercury Biopharmaceutical Corporation (6932)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Mercury Biopharmaceutical Corporation, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Mercury Biopharmaceutical Corporation de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN